Zobrazeno 1 - 10
of 35
pro vyhledávání: '"J. C. Torre"'
Autor:
Emma Beltrán, Ana Urruticoechea-Arana, E. Pascual, J. Fernández-Melón, E. Chamizo Carmona, J. M. Belzunegui Otano, J. L. Álvarez Vega, A. Hernández, J. C. Torre, I. Ros, J. Gratacos-Masmitja, Francisco Maceiras, C. Fito-Manteca
Publikováno v:
Annals of the Rheumatic Diseases. 80:1303.2-1304
Background:Apremilast is a non-biologic systemic agent approved for the treatment of plaque psoriasis, oral ulcers of Behcet’s disease and PsA with proven efficacy in clinical trials [1,2]. However, more real-world evidence of apremilast use and ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e87d4b4ddec414288b5de8627c8cc9cb
https://doi.org/10.1136/annrheumdis-2021-eular.1621
https://doi.org/10.1136/annrheumdis-2021-eular.1621
Autor:
Jesús Sanz, MA Abad, JC Cobeta, María Isabel Moreno Montoro, J. C. Torre Alonso, M.D. Romero, Rubén Queiro, F. Medina, JA Román Ivorra, J Alén Calvo, Francisco J. Rodriguez, Agustí Sellas, A Aragόn, Carlos Montilla, A Urruticoechea, S Gόmez, M Riesco, A Bermúdez, Juan D. Cañete, Ana Cabez, Mercedes García, J. Salvatierra
Publikováno v:
Poster Presentations.
Background Some cardiovascular risk factors (CVRF) have been related to poorer responses to biological therapy 1 . We aimed to evaluate the potential link between the MDA response and the presence of CVRF in patients treated with traditional and/or b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1ef796847b4153313bd80b8af015cbe
https://doi.org/10.1136/annrheumdis-2017-eular.4083
https://doi.org/10.1136/annrheumdis-2017-eular.4083
Publikováno v:
Annals of the Rheumatic Diseases. 66:493-497
Objectives: To determine the predictive factors of clinical response to infliximab in patients with refractory psoriatic polyarthritis. Methods: A multicentre open study which included 69 patients with psoriatic polyarthritis refractory to methotrexa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d0499b8d3834991517a70cd2eb0340
https://doi.org/10.1136/ard.2006.060079
https://doi.org/10.1136/ard.2006.060079
Publikováno v:
Scandinavian Journal of Rheumatology. 33:318-322
To analyse the relative role of HLA-DR antigens in the susceptibility to, and clinical expression of psoriatic arthritis (PsA).A retrospective cohort study of 120 patients with PsA who were assessed according to a standard protocol. Patients were cla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69178ca131d09c9f91799771f81c4f0
https://doi.org/10.1080/03009740410005953
https://doi.org/10.1080/03009740410005953
Autor:
Francisco Unanue, Rubén Queiro, J. Belzunegui, J. C. Torre, Carlos González, Juan R. de Dios, M.E. Figueroa
Publikováno v:
Seminars in Arthritis and Rheumatism. 31:264-270
Objectives: To analyze the clinical features of uveitis in psoriatic arthritis (PsA) and to investigate the factors predicting its appearance. Patients and Methods: Retrospective cohort study (1991-2000) of 71 patients diagnosed with PsA according to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa73d5d7aa28f842364ae8f1ae1f154b
https://doi.org/10.1053/sarh.2002.28798
https://doi.org/10.1053/sarh.2002.28798
Autor:
Cristina Sarasqueta, Rubén Queiro, J. R. De Dios, C. Gonza´lez, J. C. Torre, J. Belzunegui, M.E. Figueroa
Publikováno v:
Clinical Rheumatology. 21:10-13
The aim of this study was to analyse retrospectively the prevalence and the clinical features of clinically asymptomatic axial involvement in patients with psoriasis and axial radiological features of spondyloarthropathy (PsSpA). We performed a cross
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b4f5b677c1e1c3387a361583a463c8
https://doi.org/10.1007/s100670200003
https://doi.org/10.1007/s100670200003
Autor:
Ana Cabez, Jaime Calvo, María Montoro, Carlos Montilla, J. Salvatierra, Jesús Sanz, Rubén Queiro, Juan D. Cañete, J. C. Torre, J.A. Román-Ivorra, S Gόmez
Publikováno v:
Annals of the Rheumatic Diseases. 75:344.1-344
Background Biological therapies have greatly improved the management of psoriatic arthritis (PsA). Minimal disease activity (MDA) has become the optimal target in the treatment of PsA, waiting for a standardized definition of remission. Knowing the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dbc181dcb36d153d6948339e163fdf2
https://doi.org/10.1136/annrheumdis-2016-eular.3250
https://doi.org/10.1136/annrheumdis-2016-eular.3250
Publikováno v:
Annals of the Rheumatic Diseases. 62:68-70
To analyse the factors predicting erosive-deforming arthropathy in patients with psoriatic arthritis (PsA).A prospective cohort study was undertaken with 71 patients diagnosed as having PsA (44 men and 27 women, mean age 47 (SD 12) years). At the rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b17d865c4f2e82e103f4397cae9f99
https://doi.org/10.1136/ard.62.1.68
https://doi.org/10.1136/ard.62.1.68
Autor:
J C, Torre
Publikováno v:
Reumatologia clinica. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5e484b6d8c1b460bd6aa3106e8cd265
https://pubmed.ncbi.nlm.nih.gov/21794282
https://pubmed.ncbi.nlm.nih.gov/21794282
Publikováno v:
Reumatologia clinica. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2af54b37ec52471e6422d131640ffa73
https://pubmed.ncbi.nlm.nih.gov/21794276
https://pubmed.ncbi.nlm.nih.gov/21794276